Senior Living Needs Support for Relief & Resources: Help us tell the administration to equitably distribute Provider Relief Fund dollars to senior living providers.
Resources, links, and suggested best practices for a thoughtful approach to COVID-19 preparation and response in senior living communities.
Please note, the information included here is updated often as we learn about new resources, guidelines, and public health directives.
The FDA authorized monoclonal antibody (mAb) treatments for COVID-19 in November 2020 after these treatments were shown to be effective at combatting the disease. Since then, a pilot program was established by the U.S. Department of Health and Human Services (HHS) to increase access to bamlanivimab (Eli Lilly) for COVID-19 in high-risk, eligible individuals residing or working in long-term care facilities, including assisted living. The program utilizes home infusion providers – in partnership with community staff – to identify, assess, coordinate, dispense, and administer monoclonal antibody therapies in these healthcare settings.
We encourage interested senior living communities to have a protocol mapped out ahead of time, as these treatments must be administered ASAP upon confirmation of COVID-19 symptoms. Without a plan in place, treatment will be delayed.
Assisted living communities and skilled nursing facilities experiencing an outbreak of COVID-19 can locate a home infusion provider from the National Home Infusion Association’s HHS Bamlanivimab Pilot Provider List. Infusion providers are available in most states and can be located using this map.
Once a physician’s order has been issued following a positive COVID-19 test, these providers:
Argentum, its executive staff and consultants, have attempted to provide the best possible information as a service to the association’s membership in a situation that is very quickly evolving and about which so much is unknown. Therefore, Argentum can provide no assurances nor even make any representations about the reliability or accuracy of this information. Each senior living company and each community must make decisions that each regards as in the best interests of the health and safety of the residents. Argentum specifically disclaims responsibility or liability for the information it is providing from any legal, regulatory, medical, or compliance point of view.
Get updates on the latest news impacting senior living through our Argentum Daily newsletter.